Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ABBOTT LABORATORIES (ABT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ABBOTT LABORATORIES (ABT), most recent 12 months reported: revenue $45.13B, net income $6.28B, free cash flow $7.38B. Latest balance sheet on file: liquid cash $7.29B, total debt $34.05B, net cash -$26.75B. From SEC filings. More on ABBOTT LABORATORIES: Revenue · Profitability · Cash flow · Debt · Dividends Others in Pharmaceutical Preparations: Merck & Co., Inc. · AbbVie Inc. · PFIZER INC · BRISTOL-MYERS SQUIBB COMPANY · Universe Pharmaceuticals INC · TEVA PHARMACEUTICAL INDUSTRIES LIMITED · REGENERON PHARMACEUTICALS, INC. · VIATRIS INC.

Stock screener

Watchlist